3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: October 8, 2010
Period of Report: October 5, 2010
Accession Number: 0001437749-10-003340

View Document ↗ View on SEC.gov ↗